Research context
An erythropoietin-derived peptide studied in tissue-protection and neuropathy research.
Tissue research
An erythropoietin-derived peptide studied in tissue-protection and neuropathy research.
An erythropoietin-derived peptide studied in tissue-protection and neuropathy research.
Evidence map
Evidence levels describe study design. They do not by themselves establish safety or effectiveness.
Pharmacological Management of Diabetic Neuropathy: Current Evidence, Clinical Positioning, and Emerging Therapeutic Targets.
Phase-targeted erythropoietin derivatives for traumatic brain injury: bridging mechanisms to precision therapy.
A small erythropoietin derived non-hematopoietic peptide reduces cardiac inflammation, attenuates age associated declines in heart function and prolongs healthspan.
The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice.
Cibinetide Protects Isolated Human Islets in a Stressful Environment and Improves Engraftment in the Perspective of Intra Portal Islet Transplantation.
The time to develop treatments for diabetic neuropathy.
A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema.
Study of Efficacy of ARA 290 on Corneal Nerve Fiber Density and Neuropathic Symptoms of Subjects With Sarcoidosis
ARA290 in T2D (Effects of ARA 290, an Erythropoietin Analogue) in Prediabetes and Type 2 Diabetes)
The Use of ARA290 for the Treatment of Diabetic Macular Oedema
Cognitive and Neural Effects of ARA290
Güvenlik-özgürlük ikileminde teröre yönelik tutumlar
THE LOOK AND THE VOICE
Use of ARA 290 for the treatment of diabetic macular oedema
Environmental disclosure and firm efficiency: a study of Pakistani firms
ARA KAZANÇ TİCARETİNDEKİ (CARRY TADE) ÇÖZÜLMENİN ASİMETRİK ETKİLERİ: TÜRKİYE ÜZERİNE BİR UYGULAMA
Revista ARA
ARA 290 relieves pathophysiological pain by targeting TRPV1 channel: Integration between immune system and nociception
Possible Bone-Marrow Depression by Ara-A Therapy for Disseminated Herpes Zoster
Cibinetide dampens innate immune cell functions thus ameliorating the course of experimental colitis
A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema
The Non-Erythropoietic EPO Analogue Cibinetide Inhibits Osteoclastogenesis In Vitro and Increases Bone Mineral Density in Mice
Corneal nerve fiber size adds utility to the diagnosis and assessment of therapeutic response in patients with small fiber neuropathy
The Many Facets of Erythropoietin Physiologic and Metabolic Response
Erythropoietin and its derivatives: from tissue protection to immune regulation
ERS clinical practice guidelines on treatment of sarcoidosis
Early nerve fibre regeneration in individuals with type 1 diabetes after simultaneous pancreas and kidney transplantation
Peptides in Regenerative Medicine: A Comprehensive Review of Clinical Applications in Tissue Repair and Chronic Pain Management.
Connected data hub
Reviewed records carry an admin-reviewed badge. Automated records link back to the provider for independent checking.
Sun Y, Song B, Zhang Y, Zhang Y, Zhou L
Winicki NM, Nanavati AP, Morrell CH, Moen JM, Axsom JE, Krawczyk M, Petrashevskaya NN, Beyman MG, Ramirez C, Alfaras I, Mitchell SJ, Juhaszova M, Riordon DR, Wang M, Zhang J, Cerami A, Brines M, Sollott SJ, de Cabo...
Rendell MS
Alburghaif AH, Al-Hussaniy HA, Maan J, Razzaq NA
Luansritisakul C, Chiang MC, Burns SL, Fonseca ACG
Awida Z, Bachar A, Saed H, Gorodov A, Ben-Califa N, Ibrahim M, Kolomansky A, Iden JA, Graniewitz Visacovsky L, Liron T, Hiram-Bab S, Brines M, Gabet Y, Neumann D
Yao M, Domogatskaya A, Ågren N, Watanabe M, Tokodai K, Brines M, Cerami A, Ericzon BG, Kumagai-Braesch M, Lundgren T
Lois N, Gardner E, McFarland M, Armstrong D, McNally C, Lavery NJ, Campbell C, Kirk RI, Bajorunas D, Dunne A, Cerami A, Brines M
· University of Notre Dame Press
PurposeThe purpose of this paper is to examine the effect of environmental disclosure on firm efficiency of the listed firms in Pakistan.Design/methodology/approachThe study uses secondary sources such as sustainability reports, annual reports and company websites to collect the...
Ara kazanç ticareti, spekülatif bir finansal işlem ve kaldıraçlı döviz kuru pozisyonudur. Bu nedenle, ara kazanç ticareti pozisyonlarında meydana gelebilecek ani bir çözülme, yüksek faiz oranına sahip para biriminin sert bir şekilde değer kaybetmesine ve dolayısıyla döviz kuru...
Wenjia Zhang, Guanling Yu, Mengyuan Zhang · Elsevier BV
Jacqueline Boyd-McConville, Noemi Lois · Springer Science and Business Media LLC
· Ankara University
· Massachusetts Medical Society
· Universidade de Sao Paulo, Agencia USP de Gestao da Informacao Academica (AGUIA)
Zamzam Awida, Almog Bachar, Hussam Saed, Anton Gorodov, Nathalie Ben‐Califa, Maria Ibrahim et al. · International Journal of Molecular Sciences · 7 citations
Robert Phillip Baughman, Dominique Valeyre, Peter J. Korsten, Alexander G. Mathioudakis, Wim A Wuyts, Athol Umfrey Wells et al. · European Respiratory Journal · 632 citations
Noemi Lois, Evie Gardner, Margaret McFarland, David G. Armstrong, Christine McNally, Nuala Jane Lavery et al. · Journal of Clinical Medicine · 11 citations
Bo Peng, Gangcheng Kong, Cheng Yu Yang, Yingzi Ming · Cell Death and Disease · 179 citations
Sukanya Suresh, Praveen Kumar Rajvanshi, Constance Tom Noguchi · Frontiers in Physiology · 211 citations
Shazli Azmi, Maria Jeziorska, Maryam Ferdousi, Ioannis Nikolaos Petropoulos, Georgios Ponirakis, Andrew G. Marshall et al. · Diabetologia · 122 citations
Michael L. Brines, Daniel A. Culver, Maryam Ferdousi, Martijn Rudolf Tannemaat, Monique van Velzen, Albert Dahan et al. · Scientific Reports · 89 citations
Manfred Nairz, David Haschka, Stefanie Dichtl, Thomas Sonnweber, Andrea Schroll, Malte Aßhoff et al. · Scientific Reports · 21 citations
ARA 290-DMO is a prospective, open label, interventional, single centre, investigator led, phase II trial to examine the effect of ARA 290 on diabetic macular oedema in patients with type 1 or 2 diabetes. The aim or primary...
Studies on the hormone Erythropoietin (EPO) have indicated that EPO may have antidepressant properties. However, EPO may cause serious side-effects with repeated administration (thrombosis), which limits its usefulness as an antidepressant. ARA290 is a peptide that does not...
The purpose of this study is to determine whether ARA 290, a new class of compound, is effective in the treatment of the neuropathic symptoms of sarcoidosis. Brief interaction of ARA 290 with the innate repair receptor results...
The purpose of this study is to determine whether a non-hematopoietic erythropoietin analogue, ARA 290, exerts beneficial effects on blood glucose levels and insulin secretion in persons with prediabetes (impaired glucose tolerance, IGT, or impaired fasting glucose, IFG),...
Live discovery
Live results from PubMed, ClinicalTrials.gov and UniProt. These may not yet have been reviewed or stored in the Data Hub.
Fitzbio provides educational and research reference material. It does not diagnose, prescribe or replace advice from a qualified healthcare professional.